Prophylactic Protocol for Carboplatin Hypersensitivity in High-Risk Patients With Gynecologic Cancer.

Area of Science:

• Oncology
• Pharmacology

Background:

• Gynecologic cancer patients often undergo multiple carboplatin treatments.
• Hypersensitivity reactions (HSRs) to carboplatin increase with cumulative dosing and after treatment breaks.
• HSRs can necessitate treatment cessation or complex desensitization protocols.

Purpose of the Study:

• To implement and evaluate a prophylactic protocol to decrease the incidence and severity of carboplatin-related HSRs.
• To mitigate treatment interruptions and improve patient outcomes in gynecologic oncology.

Main Methods:

• A six-month pilot program administered 144 carboplatin infusions.
• The protocol involved oral steroid preparation, pre-infusion medication, and a titrated administration rate.
• Infusion nurses managed the protocol implementation.

Main Results:

• Zero carboplatin-related HSRs were observed in the pilot program.
• In contrast, 8% (21 patients) of patients on standard treatment experienced HSRs.
• The prophylactic protocol demonstrated complete efficacy in preventing HSRs during the study period.

Conclusions:

• The implemented prophylactic protocol is highly effective in preventing carboplatin-related hypersensitivity reactions.
• This strategy offers a promising alternative to standard care for managing HSR risk in gynecologic cancer patients.
• Further research may explore long-term efficacy and broader application of this protocol.